IBIO, INC. (IBIO) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 11.74M USD | Liabilities, Current |
| Cash and equivalents | 56.40M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 31.64M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.74M | $56.40M | $31.64M | (m) | (m) | (m) |
| 2026-03-31 | (m) | $6.50M | $47.63M | $27.19M | (m) | (m) | (m) |
| 2025-12-31 | (m) | $5.90M | $28.67M | $24.02M | (m) | (m) | (m) |
| 2025-09-30 | $49.65M | $6.05M | $28.11M | $21.47M | $65.00K | (m) | 8.21× |
| 2025-06-30 | (m) | $6.11M | $8.58M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $5.40M | $4.96M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $4.71M | $7.01M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $3.47M | $11.04M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $3.84M | $14.21M | (m) | (m) | $0.00 | (m) |
| 2024-03-31 | (m) | $21.43M | $5.30M | (m) | (m) | $0.00 | (m) |
| 2023-12-31 | (m) | $21.55M | $2.79M | (m) | (m) | $0.00 | (m) |
| 2023-09-30 | (m) | $20.71M | $1.46M | (m) | $0.00 | $0.00 | (m) |
| 2023-06-30 | (m) | $21.58M | $4.30M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $22.28M | $6.56M | (m) | $70.00K | (m) | (m) |
| 2022-12-31 | (m) | $27.77M | $3.70M | (m) | $970.00K | (m) | (m) |
| 2022-09-30 | (m) | $32.20M | $9.89M | (m) | $1.05M | (m) | (m) |
| 2022-06-30 | (m) | $30.44M | $22.68M | (m) | $1.00M | $3.90M | (m) |
| 2022-03-31 | (m) | $8.28M | $33.77M | (m) | $1.00M | $3.28M | (m) |
| 2021-12-31 | (m) | $8.35M | $39.20M | (m) | $111.00K | $1.99M | (m) |
| 2021-09-30 | (m) | $8.10M | $62.82M | (m) | $207.00K | $587.00K | (m) |
| 2021-06-30 | (m) | $6.64M | $77.40M | (m) | $426.00K | (m) | (m) |
| 2021-03-31 | (m) | $6.07M | $84.63M | (m) | $387.00K | (m) | (m) |
| 2020-12-31 | (m) | $6.10M | $91.25M | (m) | $180.00K | (m) | (m) |
| 2020-09-30 | (m) | $5.05M | $77.54M | (m) | $300.00K | (m) | (m) |
| 2020-06-30 | (m) | $5.24M | $55.11M | (m) | $75.00K | (m) | (m) |
| 2020-03-31 | (m) | $6.18M | $10.04M | (m) | $75.00K | (m) | (m) |
| 2019-12-31 | (m) | $4.74M | $3.64M | (m) | $224.00K | (m) | (m) |
| 2019-09-30 | (m) | $4.87M | $2.10M | (m) | $75.00K | (m) | (m) |
| 2019-06-30 | (m) | $3.46M | $4.42M | (m) | $97.00K | (m) | (m) |
| 2019-03-31 | (m) | $4.05M | $9.04M | (m) | $117.00K | (m) | (m) |
| 2018-12-31 | (m) | $4.45M | $13.36M | (m) | $155.00K | (m) | (m) |
| 2018-09-30 | (m) | $5.04M | $16.01M | (m) | $119.00K | (m) | (m) |
| 2018-06-30 | (m) | $2.04M | $15.93M | (m) | $75.00K | (m) | (m) |
| 2018-03-31 | (m) | $1.95M | $3.40M | (m) | $181.00K | (m) | (m) |
| 2017-12-31 | (m) | $2.04M | $7.31M | (m) | $136.00K | (m) | (m) |
| 2017-09-30 | (m) | $2.11M | $5.92M | (m) | $260.00K | (m) | (m) |
| 2017-06-30 | (m) | $2.01M | $8.09M | (m) | $175.00K | (m) | (m) |
| 2017-03-31 | (m) | $2.62M | $12.42M | (m) | $128.00K | (m) | (m) |
| 2016-12-31 | (m) | $1.87M | $16.33M | (m) | $25.00K | (m) | (m) |
| 2016-09-30 | (m) | $2.17M | $20.10M | (m) | $170.00K | (m) | (m) |
| 2016-06-30 | (m) | $2.29M | $23.01M | (m) | $484.00K | (m) | (m) |
| 2016-03-31 | (m) | $2.44M | $21.89M | (m) | $454.00K | (m) | (m) |
| 2015-12-31 | (m) | (m) | $6.73M | (m) | $202.00K | (m) | (m) |
| 2015-09-30 | (m) | (m) | $8.38M | (m) | $480.00K | (m) | (m) |
| 2015-06-30 | (m) | (m) | $9.49M | (m) | $445.00K | (m) | (m) |
| 2015-03-31 | (m) | (m) | $8.08M | (m) | $341.00K | (m) | (m) |
| 2014-12-31 | (m) | $1.48M | $7.36M | (m) | $584.00K | (m) | (m) |
| 2014-09-30 | (m) | $1.22M | $3.49M | (m) | $0.00 | (m) | (m) |
| 2014-06-30 | (m) | $395.00K | $3.59M | (m) | $205.00K | (m) | (m) |
| 2014-03-31 | (m) | $1.21M | $4.33M | (m) | $1.01M | (m) | (m) |
| 2013-12-31 | (m) | $1.66M | $5.68M | (m) | $1.01M | (m) | (m) |
| 2013-09-30 | (m) | $1.65M | $3.44M | (m) | $1.01M | (m) | (m) |
| 2013-06-30 | (m) | $4.29M | $4.41M | (m) | $1.01M | (m) | (m) |
| 2013-03-31 | (m) | $2.68M | $1.53M | (m) | $390.19K | (m) | (m) |
| 2012-12-31 | (m) | $3.09M | $2.82M | (m) | $390.19K | (m) | (m) |
| 2012-09-30 | (m) | $3.42M | $4.28M | (m) | $390.19K | (m) | (m) |
| 2012-06-30 | (m) | $3.60M | $5.62M | (m) | $351.41K | (m) | (m) |
| 2012-03-31 | (m) | $3.80M | $6.72M | (m) | $371.75K | (m) | (m) |
| 2011-12-31 | (m) | $4.71M | $623.45K | (m) | $233.83K | (m) | (m) |
| 2011-09-30 | (m) | $4.69M | $1.52M | (m) | $320.35K | (m) | (m) |
| 2011-06-30 | (m) | $7.14M | $2.84M | (m) | $344.08K | (m) | (m) |
| 2011-03-31 | (m) | (m) | $3.84M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $5.77M | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $313.83K | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $909.93K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |